Publications by authors named "Rongzu Wu"

Article Synopsis
  • Fuqi Guben Gao (FQGBG) is a botanical drug used to treat nocturia linked to kidney-yang deficiency by combining several traditional medicinal plants, but its safety and pharmacological effects need further study.
  • Recent research on FQGBG demonstrated its effectiveness in reducing urination and improving immune organ damage in rat models of kidney-yang deficiency, while also assessing its safety in a clinical trial with healthy participants.
  • The results indicated significant improvements in symptoms with no major adverse events occurring during dose escalation, although some minor side effects were reported; pharmacokinetic analysis showed varying levels of certain compounds within FQGBG.
View Article and Find Full Text PDF

Background: The prognostic significance of galectin-1 (Gal-1) expression in cancerous patients has been assessed for several years while the results remain controversial. Thus, we performed the first comprehensive meta-analysis to evaluate the prognostic value of Gal-1 expression in cancerous patients.

Methods: We searched Pubmed, Embase and Web of Science to recruit studies on the prognostic impact of Gal-1 expression in cancerous patients.

View Article and Find Full Text PDF

Background/aims: Recently, many studies have demonstrated that galectin-9 (Gal-9) exhibits altered expression and has a close association with metastasis and recurrence in various cancers. Therefore, we conducted a meta-analysis to assess the prognostic role of Gal-9 expression in solid tumours.

Methods: We searched PubMed, Embase, and Web of Science until June 2017 and identified fourteen eligible studies containing 2,408 patients to include in the meta-analysis.

View Article and Find Full Text PDF

Recently, many studies have shown that pretreatment serum albumin can be closely linked to the prognosis of cancer patients, including those with renal cell carcinoma (RCC). However, not all studies have reached the same conclusion. We therefore conducted a systematic review and meta-analysis to evaluate the prognostic value of pretreatment serum albumin in RCC patients.

View Article and Find Full Text PDF